Strategy for improving circular dichroism spectra deconvolution accuracy for macrocyclic peptides in drug discovery

Area of Science:

• Pharmaceutical Science
• Biophysical Chemistry
• Structural Biology

Background:

• Peptide therapeutics are increasingly important in drug development.
• Accurate determination of peptide conformation in solution is critical for optimizing drug candidates.
• Existing circular dichroism (CD) deconvolution models are often protein-focused and based on crystallography, limiting their accuracy for peptides in solution.

Purpose of the Study:

• To develop a novel CD deconvolution model specifically for determining peptide conformation in solution.
• To improve the accuracy of secondary structure prediction for peptides using CD spectroscopy.
• To provide a more reliable tool for peptide conformational analysis in pharmaceutical research.

Main Methods:

• Development of a new CD deconvolution model tailored for peptides.
• Creation of a calibration model using a reference set of cyclic peptides with known solution-state NMR structures.
• Comparison of the novel model's prediction accuracy against a commercial standard model.

Main Results:

• The novel CD deconvolution model demonstrated improved prediction accuracy for secondary structure determination in cyclic peptides.
• The model effectively establishes a quantitative relationship between CD spectral features and peptide secondary structures in solution.
• Performance surpassed that of existing commercial models, particularly for solution-state peptide structures.

Conclusions:

• The developed CD deconvolution method offers a significant advancement for peptide conformational analysis in solution.
• This approach has the potential to accelerate the optimization of peptide drug candidates.
• The study highlights the importance of solution-state data for building accurate predictive models in peptide science.